The decreased LAIR-1 and CD33 expression on SLE monocytes, along with the frequent abnormalities related to C1q in SLE, suggest that C1q/CD33/LAIR-1 inhibitory networks are disrupted in SLE (Fig. 2c). Here, CD33 is linked to systemic lupus erythematosus.